bmiMD Review

bmiMD: a low flat rate that rewards commitment, not loyalty to a dose

bmiMD is a high-volume telehealth weight-loss clinic that connects patients to licensed clinicians in all 50 states and says it has served more than 80,000 members. Its whole pitch is simple, and for most people it holds up: you pay one flat monthly price for compounded GLP-1 medication, and that price does not climb as your dose goes up. If you have shopped around, you know how unusual that is. Plenty of providers start you cheap and then raise the bill every time your dose increases. bmiMD doesn't, and that predictability is the main reason to consider it.

The honest verdict: this is a strong pick for someone who wants mainstream, no-drama access to semaglutide or tirzepatide at a price that stays put. It is not the right fit if you want brand-name Wegovy or Zepbound, a named pharmacy you can vet, or the freedom to leave after one month without paying more.

How the pricing actually works — by plan length, not by dose

This is the part people misread, so it's worth being precise. bmiMD's price is flat across every dose, but it varies by how long a plan you commit to up front. For compounded semaglutide, the longest commitment lands at $99 a month, stepping up as your plan gets shorter, and the month-to-month rate sits in the low one-hundreds. Compounded tirzepatide starts higher, in the high one-hundreds at its best rate and rising for shorter commitments. In plain terms: the longer you prepay, the cheaper each month gets, and your dose increases never change the number.

Every plan bundles in the things that are easy to forget to budget for — the provider visit and free shipping on every subscription order are included, not billed on the side. Compared with the category median of about $169 a month, bmiMD's semaglutide entry rate is genuinely low. Tirzepatide is pricier, as it is almost everywhere, but still competitive.

The trade-off behind the low number

That headline rate assumes you buy the longest plan. If you want to try the service for a single month and walk away, you'll pay the top of the range, not the bottom. There's nothing shady about that — it's the same prepay-and-save model gyms and meal kits use — but go in knowing the cheapest figure is a 12-month figure, not a try-it-out figure.

The medications and how they're dispensed

bmiMD prescribes compounded semaglutide and compounded tirzepatide — the same active ingredients as Ozempic/Wegovy and Mounjaro/Zepbound, made by a compounding pharmacy rather than the brand manufacturer. There is no brand-name option here, so if your goal is specifically Wegovy or Zepbound, this isn't your provider.

Beyond the two GLP-1s, bmiMD also offers a broader weight-management menu that some patients use alongside or instead of injections: a lipotropic MIC plus B12 option, metformin ER, a bupropion/naltrexone combination, and sermorelin. That makes it more of a full medical weight-loss clinic than a single-drug storefront, which is useful if a clinician decides a GLP-1 isn't right for you.

What sets bmiMD apart

• Dose-proof pricing. Your monthly cost is locked regardless of titration. As you climb from a starter dose to a full maintenance dose, the bill doesn't follow you up.
• Everything-included plans. The provider visit and shipping are baked in, so the advertised price is close to the price you actually pay.
• Nationwide reach and scale. Coverage in all 50 states and a member base it puts north of 80,000 — this is an established operation, not a pop-up.
• A real clinic menu. Lipotropic injections, metformin ER, bupropion/naltrexone, and sermorelin give clinicians more than one lever to pull.

Who should choose it — and who should skip it

Choose bmiMD if you want a low, predictable monthly cost for compounded GLP-1s, you're comfortable committing to a longer plan to get the best rate, and you value an all-in-one clinic that can offer alternatives if a GLP-1 stalls. The flat-per-dose structure is a real advantage for anyone who expects to titrate up over time.

Skip it if you need brand-name medication, or if you want to start month-to-month at the lowest price (you can't; short plans cost more). Skip it, too, if you're the type who wants the specific compounding pharmacy and its accreditation named before you commit. bmiMD does not publish a named compounding partner, and for some patients that transparency matters.

Trust, safety, and medical oversight

On the reassuring side, there are no FDA warning letters on file for bmiMD, and the company is explicit that prescriptions come from licensed healthcare professionals across all 50 states with a provider visit built into every plan. That's the baseline you want from a telehealth weight-loss service, and bmiMD clears it.

The caveat is transparency. bmiMD hasn't always advertised its pricing openly; the actual rates live on its semaglutide and tirzepatide product pages rather than up front. It also doesn't disclose a named, accredited compounding pharmacy. None of that is disqualifying, but it does mean you're trusting the brand rather than a supply chain you can check yourself. If pharmacy accreditation is a dealbreaker for you, ask directly before you sign up. You can see how we weigh factors like this in our scoring methodology.

Bottom line

bmiMD does one thing very well: it makes compounded GLP-1 treatment cheap and predictable, with the provider visit and shipping included and no dose-based price creep. Semaglutide at $99 a month on the longest plan is an aggressive rate, and tirzepatide is fairly priced for what it is. The two real catches are that the best prices require a longer commitment, and that bmiMD asks for more trust on pharmacy transparency than the most open providers do. If those trade-offs sit fine with you, it's one of the better-value mainstream options for getting started.

Worth pricing against Embody ($79/month) and CoreAge Rx ($99/month) before you commit — both sit close to bmiMD on cost and formulation.